Scope:
- Solid cancers: NSCLC, CRC, Breast, Gastric, GIST, Melanoma, Thyroid, Liver, Kidney, Prostate, Head and Neck
- Liquid cancers: MDS/MPN, AML, ALL, CML, CLL, Hodgkin’s lymphomas, non-Hodgkin’s lymphomas
- Comprehensive coverage of genomic variants as well as gene and protein expression alterations.
- Scientific mechanism and clinical interpretation of association with disease diagnosis, prognosis, treatment and drug response.
- Integration with public database to allow user-led investigation of variants.
- EBM evidence classification to support confident decision making.
- Full collection of FDA approved and investigational treatment.
- Clinical trials matching with automatic search and manual filtration.
- Concordance with HGVS nomenclature and clinical guidelines.
- Standalone database accessible through API.
